Navi Medical Technologies is a Melbourne-born medical technology company with a vision of creating brighter, healthier futures for critically-ill children. Founded by a multidisciplinary team of clinicians, engineers and entrepreneurs, Navi develops technologies that help clinicians place and monitor central vascular access devices in newborns and children.
Its flagship product, the Neonav® ECG Tip Location System, uses the heart’s electrical signals to guide catheter tip positioning in real time, giving clinicians valuable information at the bedside and offering an alternative to relying solely on post-procedure X-ray.
Neonav received US FDA clearance in 2025 and is now being introduced to leading paediatric hospitals across the United States. From its base at Melbourne Connect, Navi brings together clinical insight, engineering ingenuity and commercial ambition to translate Australian research into global healthcare impact.
